Computer Science ›› 2023, Vol. 50 ›› Issue (11A): 221200113-8.doi: 10.11896/jsjkx.221200113
• Artificial Intelligence • Previous Articles Next Articles
ZHANG Qi1, PAN Ke2, ZHU Kai3
CLC Number:
[1]SANTARIUS T,SHIPLEY J,BREWER D,et al.A census of amplified and overexpressed human cancer genes[J].Nature Reviews Cancer,2010,10(1):59-64. [2]ALÓPEZ-CORTÉS,C PAZ-Y-MIÑO,GUERRERO S,et al.OncoOmics approaches to reveal essential genes in breast cancer:a panoramic view from pathogenesis to precision medicine[J].Scientific Reports,2020,10(1). [3]LV K,YANG J,SUN J,et al.Identification of key candidate genes for pancreatic cancer by bioinformatics analysis[J].Experimental and Therapeutic Medicine,2019,18(1). [4]TOMCZAK K,CZERWINSKA P,WIZNEROWICZ M.TheCancer Genome Atlas(TCGA):An immeasurable source of knowledge[J].Contemporary Oncology,2015,19(1A):A68-77. [5]HUDSON T J.International network of cancer genome projects[J].Nature,2010,464(7291):993. [6]HE H,LIN D,ZHANG J,et al.Comparison of statistical methods for subnetwork detection in the integration of gene expression and protein interaction network[J].BMC Bioinformatics,2017,18(1):149. [7]SHAH S D,BRAUN R.genesurrounder:network-based identification of disease genes in expression data[J].BMC Bioinformatics,2019,229(20). [8]QIU Y Q,ZHANG S,ZHANG X S,et al.Detecting disease associated modules and prioritizing active genes based on high throughput data[J].BMC Bioinformatics,2010,11(1):1-12. [9]FREDERIK G,B GWÉNOLA,CLAIRE V,et al.Network-based analysis of omics data:The LEAN method[J].Bioinformatics,2017(5):701-709. [10]LIU Y,BROSSARD M,D ROQUEIRO,et al.SigMod:an exact and efficient method to identify a strongly interconnected disease-associated module in a gene network[J].Bioinformatics,2017,33(10):1536-1544. [11]VLAIC S,CONRAD T,TOKARSKI S C,et al.ModuleDiscoverer:identification of regulatory modules in protein-protein interaction networks[J].Scientific Reports,2018,8(1):1-11. [12]TIAN Y,SU X,SU Y,et al.EMODMI:A multi-objective optimization based method to identify disease modules[J].IEEE Transactions on Emerging Topics in Computational Intelligence,2020,5(4):570-582. [13]WU J,ZHANG Q,LI G.Identification of cancer-related module in protein-protein interaction network based on gene prioritization [J].Journal of Bioinformatics and Computational Biology,2022,20(1). [14]LI Y,RATA I,CHIU S,et al.Improving predicted protein loop structure ranking using a Pareto-optimality consensus method[J].BMC Structural Biology,2010,10(1):1-14. [15]ZOU K H,KEMAL T,SILVERMAN S G.Correlation and simple linear regression[J].Radiology,2003,227(3):617-622. [16]BHATTACHARYYA A.On a measure of divergence between two statistical populations defined by their probability distributions[J].Bull Calcutta Math Soc,1943,35:99-109. [17]VAPNIK V,Statistical Learning Theory[M].New York:John Wiley,1998. [18]SMOLA A J,KONDOR R.Kernels and Regularization onGraphs[J].Learning Theory and Kernel Machines,2003,(12):144-158. [19]CHANG C C,LIN C J.LIBSVM:A library for support vector machines[J].ACM Transactions on Intelligent Systems and Technology,2011,2(3):1-27. [20]ANASTASIS O,GEORGE M,MARGARITA Z,et al.Systems Bioinformatics:increasing precision of computational diagnostics and therapeutics through network-based approaches[J].Briefings in Bioinformatics,2019,20(3):806-824. [21]PATIL A,NAKAMURA H.HINT:a database of annotatedprotein-protein interactions and their homologs[J].Biophysics,2005,1(364):21-24. [22]HAMOSH A.Online Mendelian Inheritance in Man(OMIM),a knowledgebase of human genes and genetic disorders[J].NucleicAcids Research,2002,30(1):52-55. [23]SUBHASH,M,AGARWAL,et al.CCDB:a curated database of genes involved in cervix cancer[J].Nucleic Acids Research,2011,39(suppl_1):975-979. [24]AGARWAL S M,RAGHAV D,SINGH H,et al.CCDB:a curated database of genes involved in cervix cancer[J].Nucleic Acids Research,2010,39(suppl_1):D975-D979. [25]MEHTA M S,VAZQUEZ A,KULKARNI D A,et al.Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes[J].Breast Cancer Research and Treatment,2011,125(3):861-868. [26]LIM N,TOWNSEND P A.Cdc6 as a novel target in cancer:Oncogenic potential,senescence and subcellular localisation[J].International Journal of Cancer,2020,147(6):1528-1534. [27]KARIMI D F,GHOLAMZADEH K S,AFSHAR S,et al.The potential role of nucleophosmin(NPM1) in the development of cancer[J].Journal of Cellular Physiology,2021,236(11):7832-7852. [28]SINHA D.Strategic inhibition of CEP55 in aggressive breastcancer leads to mitotic catastrophe[J].Annals of Oncology,2019,30:v1. [29]QIU Y T,WANG W J,ZHANG B,et al.MCM7 amplification and overexpression promote cell proliferation,colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway[J].Oncology Reports,2017,37(6):3590-3596. [30]DENG M,SUN J,XIE S,et al.Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin[J].Molecular Medicine Reports,2019,20(3):2258-2266. [31]WANG Z,FUKUSHIMA H,INUZUKA H,et al.Skp2 is apromising therapeutic target in breast cancer[J].Frontiers in Oncology,2012,1:57. [32]MA H,JIN G,HU Z,et al.Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women[J].International Journal of Cancer,2006,119(9):2173-2178. [33]SHAHIDSALES S,MEHRAMIZ M,GHASEMI F,et al.A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer[J].Journal of Clinical Laboratory Analysis,2018,32(1):e22190. [34]TADESSE S,CALDON EC,TILLEY W,et al.Cyclin dependent kinase 2 inhibitors in cancer therapy:an update[J].Journal of Medicinal Chemistry,2018,62(9):4233-4251. [35]GAN Y,LI Y,LI T,et al.CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer[J].Cancer Management and Research,2018,10:5113. [36]MELLING N,MUTH J,SIMON R,et al.Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer[J].Diagnostic Pathology,2015,10(1):1-7. [37]WANG D,LI Q,LI Y,et al.The role of MCM5 expression in cervical cancer:Correlation with progression and prognosis[J].Biomedicine & Pharmacotherapy,2018,98:165-172. [38]XIE B,NAGALINGAM A,KUPPUSAMY P,et al.Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes[J].Scientific Reports,2017,7(1):1-14. [39]FARHAN M,WANG H,GAUR U,et al.FOXO signaling pathways as therapeutic targets in cancer[J].International Journal of Biological Sciences,2017,13(7):815. [40]MA C X.The PI3K pathway as a therapeutic target in breast cancer[J].American Journal of Hematology/Oncology,2015,11(3). [41]YANG J,NIE J,MA X,et al.Targeting PI3K in cancer:mechanisms and advances in clinical trials[J].Molecular Cancer,2019,18(1):1-28. [42]THOMAS S J,SNOWDEN J A,ZEIDLER M P,et al.The role of JAK/STAT signalling in the pathogenesis,prognosis and treatment of solid tumours[J].British Journal of Cancer,2015,113(3):365-371. [43]WU L,YANG X.Targeting the Hippo pathway for breast cancertherapy[J].Cancers,2018,10(11):422. [44]HARDY K M,BOOTH B W,HENDRIX M J C,et al.ErbB/EGF signaling and EMT in mammary development and breast cancer[J].Journal of Mammary Gland Biology and Neoplasia,2010,15(2):191-199. [45]PAZ-Y-MIÑO C,LÓPEZ-CORTÉS A,MUÑOZ M J,et al.Incidence of the L858R and G719S mutations of the epidermal growth factor receptor oncogene in an Ecuadorian population with lung cancer[J].Cancer Genetics and Cytogenetics,2010,196(2):201-203. [46]ZUGMAIER G,ENNIS B W,DESCHAUER B,et al.Transforming growth factors type beta1 and beta2 are equipotent growth inhibitors of human breast cancer cell lines[J].Journal of Cellular Physiology,1989,141(2):353-361. [47]LIU Z,SEMENZA G L,ZHANG H.Hypoxia-inducible factor 1 and breast cancer metastasis[J].Journal of Zhejiang University-SCIENCE B,2015,16(1):32-43. [48]LI N,HUANG D,LU N,et al.Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells[J].Oncology Reports,2015,34(6):2821-2826. [49]RAKHA E A,EL-SHEIKH S E,KANDIL M A,et al.Expression of BRCA1 protein in breast cancer and its prognostic significance[J].Human Pathology,2008,39(6):857-865. [50]ZHANG X,LI F,ZHU L.Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer[J].Life Sciences,2018,209:242-248. [51]HU Y,ZENG Q,LI C,et al.Expression profile and prognostic value of SFN in human ovarian cancer[J].Bioscience Reports,2019,39(5). [52]LAUTER K B,ARNOLD A.Mutational analysis of CDKN1B,a candidate tumor-suppressor gene,in refractory secondary tertiary hyperparathyroidism[J].Kidney International,2008,73(10):1137-1140. [53]CUSAN M,MUNGO G,DE MARCO ZOMPIT M,et al.Landscape of CDKN1B mutations in luminal breast cancer and other hormone-driven human tumors[J].Frontiers in Endocrinology,2018,9:393. [54]ACUNER-OZBABACAN E S,ENGIN B H,GUVEN-MA-IOROV E,et al.The structural network of Interleukin-10 and its implications in inflammation and cancer[J].BMC Genomics,2014,15(4):1-17. [55]SZYMAŃSKA K,HAINAUT P.TP53 and mutations in human cancer[J].Acta Biochimica Polonica,2003,50(1):231-238. [56]HU Q L,XU Z P,LAN Y F,et al.miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer[J].The Kaohsiung Journal of Medical Sciences,2020,36(5):328-335. [57]WU S H,ZENG X F,WANG P,et al.The Expression and Significance of c-myc and bcat1 in Cervical Cancer[J].Sichuan da xue xue bao.Journal of Sichuan University(Medical Science Edition),2018,49(5):725-730. [58]SHEN K,YE Y J,JIANG K W,et al.MSH2 is required for cell proliferation,cell cycle control and cell invasiveness in colorectal cancer cells[J].Chinese Science Bulletin,2012,57(20):2580-2585. [59]SHEN S N,WANG H,GONG B L.Expressions of miRNA29target genes CCND2 and CDK6 in cervical cancer[J].Disc Clin Cases,2018,5:14-18. [60]FU H C,YANG Y C,CHEN Y J,et al.Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation[J].Oncotarget,2016,7(28):44047. [61]ZUO Q,ZHENG W,ZHANG J,et al.Methylation in the promoters of HS3ST2 and CCNA1 genes is associated with cervical cancer in Uygur women in Xinjiang[J].The International Journal of Biological Markers,2014,29(4):354-362. [62]GENG F G.A Functional Module Detection Method byCombining Cancer Multi-omics Data and PPINetwork [D].Xi’an:Xidian University,2019. [63]FU K,ZHANG L,LIU R,et al.MiR-125 inhibited cervical cancerprogression by regulating VEGF and PI3K/AKT signaling pathway[J].World Journal of Surgical Oncology,2020,18:1-10. [64]FARHAN M,WANG H,GAUR U,et al.FOXO signaling pathways as therapeutic targets in cancer[J].International Journal of Biological Sciences,2017,13(7):815. [65]GUTIÉRREZ-HOYA A,SOTO-CRUZ I.Role of the JAK/STAT Pathway in Cervical Cancer:Its Relationship with HPV E6/E7 Oncoproteins[J].Cells,2020,9(10):2297. [66]HE C,MAO D,HUA G,et al.The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression[J].EMBO Molecular Medicine,2015,7(11):1426-1449. |
[1] | ZHANG Xi-ke, MA Zhi-qing, ZHAO Wen-hua, CUI Dong-mei. Review on Classification of Breast Cancer Histopathological Images Based on Convolutional Neural Network [J]. Computer Science, 2022, 49(11A): 210800232-9. |
[2] | WU Xiao-wen, ZHENG Qiao-xian, XU Xin-qiang. Improved Ant Colony Algorithm for Solving Multi-objective Unilateral Assembly Line Balancing Problem [J]. Computer Science, 2022, 49(11A): 210900165-5. |
[3] | GAO Shi-shun, ZHAO Hai-tao, ZHANG Xiao-ying, WEI Ji-bo. Self-adaptive Intelligent Wireless Propagation Model to Different Scenarios [J]. Computer Science, 2021, 48(7): 324-332. |
[4] | HE Qing-fang, WANG Hui, CHENG Guang. Research on Classification of Breast Cancer Pathological Tissues with Adaptive Small Data Set [J]. Computer Science, 2021, 48(6A): 67-73. |
[5] | WANG Guo-wu, CHEN Yuan-yan. Improvement of DV-Hop Location Algorithm Based on Hop Correction and Genetic Simulated Annealing Algorithm [J]. Computer Science, 2021, 48(6A): 313-316. |
[6] | MAN Rui, YANG Ping, JI Cheng-yu, XU Bo-wen. Survey of Classification Methods of Breast Cancer Histopathological Images [J]. Computer Science, 2020, 47(11A): 145-150. |
[7] | REN Xue-ting, ZHAO Juan-juan, QIANG Yan, Saad Abdul RAUF, LIU Ji-hua. Lung Cancer Subtype Recognition with Unsupervised Learning Combining Paired Learning and Image Clustering [J]. Computer Science, 2020, 47(10): 200-206. |
[8] | XU Fei-xiang,YE Xia,LI Lin-lin,CAO Jun-bo,WANG Xin. Comprehensive Calculation of Semantic Similarity of Ontology Concept Based on SA-BP Algorithm [J]. Computer Science, 2020, 47(1): 199-204. |
[9] | CAI Qi-rong, WU Jing-li. Model and Algorithm for Identifying Driver Pathways in Cancer by Integrating Multi-omics Data [J]. Computer Science, 2019, 46(9): 310-314. |
[10] | ZHANG Xue-fu, ZENG Pan, JIN Min. Cancer Classification Prediction Model Based on Correlation and Similarity [J]. Computer Science, 2019, 46(7): 300-307. |
[11] | CHEN Si-wen, LIU Yu-jiang, LIU Dong, SU Chen, ZHAO Di, QIAN Lin-xue, ZHANG Pei-heng. AlexNet Model and Adaptive Contrast Enhancement Based UltrasoundImaging Classification [J]. Computer Science, 2019, 46(6A): 146-152. |
[12] | TANG Jia-qi, WU Jing-li, LIAO Yuan-xiu, WANG Jin-yan. Prediction of Protein Functions Based on Bi-weighted Vote [J]. Computer Science, 2019, 46(4): 222-227. |
[13] | LIU Jing-fa, LI Fan, JIANG Sheng-yi. Focused Annealing Crawler Algorithm for Rainstorm Disasters Based on Comprehensive Priority and Host Information [J]. Computer Science, 2019, 46(2): 215-222. |
[14] | WANG Jie, LIANG Ji-ye, ZHAO Xing-wang, ZHENG Wen-ping. Overlapping Protein Complexes Detection Algorithm Based on Assortativity in PPI Networks [J]. Computer Science, 2019, 46(2): 294-300. |
[15] | GUO Bing, ZHENG Wen-ping, HAN Su-qing. Driver Pathway Identification Algorithm Based on Mutated Gene Networks for Cancer [J]. Computer Science, 2018, 45(7): 230-236. |
|